Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Finalizing Review Principles Guidance; Complete Submissions Urged

Jun 21 2004

• By The Pink Sheet

Related Content

FDA Has “Issues” With NDAs; Half Of 74-Day Letters Note Application Flaws

Apr 21 2003

FDA Defines Good Review Management; No Data In Labeling Negotiations

Jul 28 2003

Second Continuous Marketing Application Pilot Program Is 44% Enrolled

Mar 15 2004

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window